Braidwell LP boosted its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 567.6% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 1,176,173 shares of the company’s stock after purchasing an additional 1,000,000 shares during the period. Braidwell LP’s holdings in Cullinan Therapeutics were worth $19,689,000 at the end of the […]

Braidwell LP reduced its stake in Castle Biosciences, Inc. (NASDAQ:CSTL – Free Report) by 20.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 331,986 shares of the company’s stock after selling 84,114 shares during the period. Braidwell LP’s holdings in Castle […]